Clinical Trial Update: Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of conestat alfa for ACE inhibitor-induced angioedema is described. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ace Inhibitor-induced Angioedema

Drugs mentioned

• Conestat Alfa (conestat alfa)

Snippet

Sponsor: University of Cincinnati | Conditions: ACE Inhibitor-Induced Angioedema | Phase 3 | Status: NOT_YET_RECRUITING